VARITHENA: payments to doctors
Payments that named VARITHENA as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $675K
- Providers
- 2,188
- Transactions
- 4,136
- Average per transaction
- $163
The per-transaction average — $163 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 2,188 providers the average total is $308, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Biocompatibles, Inc. | $425,921 | 63.1% |
| Boston Scientific | $237,060 | 35.1% |
| Biocompatibles UK Ltd | $10,000 | 1.5% |
| BTG International, Inc. | $1,434 | 0.2% |
| EKOS Corporation | $400 | 0.1% |